OBN’s Corporate Membership of 400-plus organisations includes many R&D companies (therapeutic, medical technology and diagnostics) as well as an extensive range of contract research (CRO) and manufacturing (CMO) organisations, companies in the associated industries and specialists suppliers.
The membership breakdown by sector can be accessed by clicking on the down arrow on the right of the search box.
Search for companies by:
- Sector/Subsector using the dropdown box below
- Keyword search using the box on the right
- Alphabetical listing
Please note that only details of current OBN Members appear here.
Calcico Therapeutics LtdCalcico Therapeutics LtdCalcico focuses on the development of novel CRAC channel inhibitors
Calcico is a venture backed biotechnology company focused on the development of novel CRAC channel inhibitors. The company aims to develop selective small molecules to treat a range of inflammatory and autoimmune conditions where there is clear evidence linking CRAC to human disease.
Calcico was spun-out from Oxford University in April 2012 and funded by Advent Life Sciences and Imperial Innovations. The company has developed proprietary ‘know-how’ comprising novel systems for selective CRAC channel screening and molecule characterisation. This puts us in a unique position to achieve the goal of potent and selective CRAC channel inhibition, which has so far eluded pharmaceutical companies.
Contact; Fraser Murray, email@example.com
Cambridge Innovation Capital plcCambridge Innovation Capital plcCambridge Innovation Capital is an investment fund that invests in high-growth technology companies
Cambridge Innovation is led by an experienced investment team, an outstanding board and advisory panel of leading scientists and entrepreneurs
Cello Health ConsultingCello Health ConsultingCommercialisation and Route to Market Strategy ConsultingContact: Michael Craig
Cello Health Consulting is a successful and rapidly growing global strategy consultancy dedicated to healthcare. We have offices in the UK – London & Farnham and the USA – Boston, New York and Philadelphia.
We work alongside our clients to create practical, winning solutions which ensure buy-in and commercial success. We are focused on 6 practice areas: • Early Asset Development and Commercialisation • Scenario Learning & Competitor Strategy • Segmentation and Positioning • Launch Excellence • Brand and Portfolio Strategy • Brand Team Excellence.
Cello Health Consulting is part of Cello Health – A worldwide team of 400 people, providing a fusion of expertise in market research, strategic consultancy and scientific communications. This fusion of expertise generates the spark of energy needed to unlock the potential of your assets, brands and organisational talent.
Clinical Network Services (UK) LtdClinical Network Services (UK) LtdClinical Network Services (CNS) is an Australian and New Zealand service group, offering full and integrated drug development consultancy to small & medium sized Biotech companies from inception through to end of phase II clinical trial programs
CN Bio Innovations LtdCN Bio Innovations LtdCN Bio develops and supplies cell culture platforms that support more physiologically relevant tissue models for pharmaceutical drug discovery applications
The lead product is Liver Chip, a 3D culture platform which mimics the architecture and physiology of the liver